Bird Flu
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine (NCT01675284) | Medigen Biotechnology Corporation | 2012-08-01 |
| Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 (NCT01006798) | Emergent BioSolutions | 2009-10-01 |
Track Bird Flu automatically
Every clearance here is in the API, with alerts when new ones post.